Sat.Jul 30, 2022 - Fri.Aug 05, 2022

Remove covid-19
article thumbnail

Elixinol confirms new CEO and shift away from CBD

Cannabis Law Report

expected from US Covid-19 relief measures. The company reported Q2 FY22 revenue of A$1.7m, up 13% on the previous quarter, while operating cash used was down 36% to $2.1m. It finished the quarter with $8.5m in funds, including $6.9m in cash and an additional $1.6m

CBD 52
article thumbnail

Folium Biosciences forced out of business by its private equity backer

Cannabis Law Report

of Justice will pursue criminals charges against the company and its executives for allegedly using a false number of full time staff employees to get millions in PPP loan money during the height of the Covid-19 pandemic. There is also the burning question as to whether the Dept.